Home » Topics » Briefs » Other news to note

Other news to note
RSS

GSK adds development candidate to its collaboration with Isis

Oct. 8, 2013

Amplimmune acquisition strengthens MedImmune's oncology pipeline

Oct. 7, 2013

PharmAkea Therapeutics and Celgene to advance therapies for cancer and fibrotic disease

Oct. 7, 2013

Astellas Pharma establishes new organization to oversee external alliance activities

Oct. 4, 2013

Two lupus organizations form collaboration to identify potential new treatments for the disease

Oct. 4, 2013

Actavis completes acquisition of Warner Chilcott

Oct. 3, 2013

Bioheart forms license agreement with Invitrx

Sep. 27, 2013

Retrophin makes new proposal to acquire Transcept

Sep. 25, 2013

GlaxoSmithKline receives orphan drug designations in Japan for multiple drugs

Sep. 20, 2013

Daiichi Sankyo and Mitsubishi UFJ Capital establish new open innovation business

Sep. 20, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...